EUVIMEDDescoperă EUVIMED
ÜbersichtsarbeitSystematische ÜbersichtOpen access · CC BY 4.0

Therapeutic potential of okra ( Abelmoschus esculentus ) in dysglycaemia and metabolic dysfunction: A systematic review and meta‐analysis across the diabetes spectrum

Therapeutic potential of okra (Abelmoschus esculentus) in dysglycaemia and metabolic dysfunction: Eine systematische Übersicht und Metaanalyse über das Diabetes-Spektrum

Ali Jafari iD, Helia Mardani, Mohammad Amin Karimi, MohammadHossein Sahami Gilan, Helia Hemmat, Fatemeh Shoja, Nooshin Enayati Soofi, Ghazaleh Eslamian iD

Experimental Physiology · 2026-03-13

DOI: 10.1113/ep093293 ↗

Auf einen Blick

14 RCTs mit 836 Teilnehmenden zeigen unter Okra-Supplementierung Verbesserungen bei Glukose- und Lipidparametern. Die Evidenz war für die meisten Endpunkte sehr niedrig.

Fragestellung

Welche Wirkung hat Okra-Supplementierung auf metabolische Risikofaktoren bei Diabetes?

Methode

Systematische Übersicht und Metaanalyse von RCTs; Suche in PubMed, Scopus, Web of Science, EMBASE und Cochrane Library bis 23. Juli 2025.

Ergebnisse

14 RCTs mit 836 Teilnehmenden. Signifikante Reduktionen bei 2-h-Postprandialglukose, Nüchternblutzucker, HbA1c, HOMA-IR, LDL-Cholesterin und Gesamtcholesterin.

Einschränkungen

Kleine und heterogene Studien; Evidenz für die meisten Endpunkte sehr niedrig.

Schlussfolgerung der Autor:innen

Okra-Supplementierung könnte die glykämische Kontrolle und das Lipidprofil verbessern und hat potenzielles Potenzial als ergänzender Ansatz in der Diabetesbehandlung.

Kernaussagen

  • 2-h-Postprandialglukose, Nüchternblutzucker und HbA1c sanken unter Okra
  • Auch HOMA-IR sowie LDL- und Gesamtcholesterin reduzierten sich
  • Die Evidenz war überwiegend sehr niedrig

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Übersichtsarbeit in Experimental Physiology, published online on 2026-03-13. Written by Ali Jafari and 7 co-authors. Institution: Student Research Committee, Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technol…. Cited 3 times so far (Crossref); 68 references. The full text is freely available (open access, CC BY 4.0).

Auf einen BlickRezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

The aim of this systematic review and meta‐analysis was to evaluate comprehensively the therapeutic potential of Abelmoschus esculentus (okra) supplementation across the diabetes spectrum of key metabolic risk factors. A search was conducted in PubMed, Scopus, Web of Science, EMBASE and the Cochrane Library, up to 23 July 2025, to identify randomized controlled trials evaluating the effects of okra supplementation on metabolic risk factors in diabetes. Fourteen randomized controlled trials published between 2020 and 2025, including a total of 836 participants, were analysed. Okra supplementation led to significant reductions in 2 h postprandial glucose [weighted mean difference (WMD) = −22.39 mg/dL, 95% confidence interval (CI): −41.39 to −3.38; P = 0.021], fasting blood sugar (WMD = −23.66 mg/dL, 95% CI: −34.20 to −13.12; P < 0.001), glycosylated haemoglobin (WMD = −0.30%, 95% CI: −0.59 to −0.02; P = 0.034), homeostatic model assessment for insulin resistance (WMD = −0.59 units, 95% CI: −1.01 to −0.18; P = 0.005), low‐density lipoprotein cholesterol (WMD = −8.55 mg/dL, 95% CI: −14.42 to −2.68; P = 0.004) and total cholesterol (WMD = −12.58 mg/dL, 95% CI: −22.78 to −2.37; P = 0.016) levels. The certainty of evidence was very low for most outcomes, except for diastolic blood pressure and glycosylated haemoglobin, which were rated as low. Regarding methodological quality, six trials were rated as good, two as fair and six as poor. Okra supplementation might improve glycaemic control and lipid profiles, indicating its potential as a complementary approach in diabetes management. Despite limitations from small and heterogeneous trials, these findings support future research on optimal dosing, safety and personalized applications in metabolic disease management.

Subjects

Author keywords

Abelmoschus esculentusglycaemic profilelipid profilemeta‐analysisokra

Authors and institutions

  • Student Research Committee, Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences…
  • Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Nursing, Faculty of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran.
  • Electronic Health and Statistics Surveillance Research Center, SRC, Islamic Azad University, Tehran, Iran.

ORCID profiles: Ali Jafari, Ghazaleh Eslamian

Cite

APA

Jafari, A., Mardani, H., Karimi, M. A., Sahami Gilan, M., Hemmat, H., Shoja, F., Enayati Soofi, N., & Eslamian, G. (2026). Therapeutic potential of okra ( Abelmoschus esculentus ) in dysglycaemia and metabolic dysfunction: A systematic review and meta‐analysis across the diabetes spectrum. Experimental Physiology. https://doi.org/10.1113/ep093293

Vancouver

Jafari A, Mardani H, Karimi MA, Sahami Gilan M, Hemmat H, Shoja F, et al. Therapeutic potential of okra ( Abelmoschus esculentus ) in dysglycaemia and metabolic dysfunction: A systematic review and meta‐analysis across the diabetes spectrum. Experimental Physiology. 2026. doi:10.1113/ep093293

BibTeX
@article{Jafari2026,
  author = {Jafari, Ali and Mardani, Helia and Karimi, Mohammad Amin and Sahami Gilan, MohammadHossein and Hemmat, Helia and Shoja, Fatemeh and Enayati Soofi, Nooshin and Eslamian, Ghazaleh},
  title = {Therapeutic potential of okra ( Abelmoschus esculentus ) in dysglycaemia and metabolic dysfunction: A systematic review and meta‐analysis across the diabetes spectrum},
  journal = {Experimental Physiology},
  year = {2026},
  doi = {10.1113/ep093293}
}
Start for free →